CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 4.450
+0.160 (3.73%)
Jun 25, 2025, 4:08 PM HKT
CStone Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 387.94 | 996.67 | 558.68 | 742.72 | 3,025 | Upgrade
|
| Short-Term Investments | 331.95 | 51.85 | 588.91 | 913.07 | 536.91 | Upgrade
|
| Trading Asset Securities | - | - | - | 122.9 | 10.13 | Upgrade
|
| Cash & Short-Term Investments | 719.88 | 1,049 | 1,148 | 1,779 | 3,572 | Upgrade
|
| Cash Growth | -31.34% | -8.63% | -35.48% | -50.20% | 23.75% | Upgrade
|
| Accounts Receivable | 83.93 | 172.44 | 77.13 | 117.6 | - | Upgrade
|
| Receivables | 83.93 | 172.44 | 77.13 | 117.6 | - | Upgrade
|
| Inventory | 286.1 | 108.83 | 22.19 | 61.36 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.72 | Upgrade
|
| Total Current Assets | 1,090 | 1,330 | 1,247 | 1,958 | 3,572 | Upgrade
|
| Property, Plant & Equipment | 130.54 | 153.37 | 206.57 | 182.8 | 66.54 | Upgrade
|
| Long-Term Investments | 9.03 | 3.54 | 3.48 | 3.19 | - | Upgrade
|
| Other Intangible Assets | 161.37 | 173.05 | 159.7 | 70.54 | 6.51 | Upgrade
|
| Other Long-Term Assets | 2.62 | 2.26 | 21.76 | 57.28 | 117.4 | Upgrade
|
| Total Assets | 1,393 | 1,662 | 1,638 | 2,271 | 3,763 | Upgrade
|
| Accounts Payable | 338.03 | 246.38 | 290.41 | 414.29 | 28.03 | Upgrade
|
| Accrued Expenses | 195.23 | 372.28 | 400.87 | 400.65 | 551.19 | Upgrade
|
| Current Portion of Long-Term Debt | 60.8 | 105.99 | 8.57 | 30.7 | 2.66 | Upgrade
|
| Current Portion of Leases | 32.42 | 33.33 | 36.35 | 13.25 | 8.65 | Upgrade
|
| Current Income Taxes Payable | 1.77 | 17.66 | 5.82 | 24.29 | 6.09 | Upgrade
|
| Current Unearned Revenue | 10.39 | 6.89 | 7 | 7.45 | 7.21 | Upgrade
|
| Other Current Liabilities | 43.37 | 67.82 | 197.46 | 42.31 | 123.21 | Upgrade
|
| Total Current Liabilities | 682.01 | 850.34 | 946.48 | 932.95 | 727.05 | Upgrade
|
| Long-Term Debt | 257.4 | 213 | 218.99 | 115.81 | 54.34 | Upgrade
|
| Long-Term Leases | 5.36 | 11.14 | 22.39 | 14.44 | 18.21 | Upgrade
|
| Long-Term Unearned Revenue | 84.83 | 61.97 | 1.25 | 1.25 | 8.7 | Upgrade
|
| Other Long-Term Liabilities | - | 68.73 | - | - | - | Upgrade
|
| Total Liabilities | 1,030 | 1,205 | 1,189 | 1,064 | 808.29 | Upgrade
|
| Common Stock | 0.86 | 0.86 | 0.8 | 0.8 | 0.79 | Upgrade
|
| Additional Paid-In Capital | 9,004 | 8,992 | 8,628 | 8,465 | 8,324 | Upgrade
|
| Retained Earnings | -9,111 | -9,020 | -8,652 | -7,750 | -5,830 | Upgrade
|
| Treasury Stock | -0.01 | -0.01 | -0 | -0.01 | -0.02 | Upgrade
|
| Comprehensive Income & Other | 469.99 | 483.25 | 473.09 | 491.44 | 459.09 | Upgrade
|
| Total Common Equity | 363.87 | 456.83 | 449.33 | 1,207 | 2,954 | Upgrade
|
| Shareholders' Equity | 363.87 | 456.83 | 449.33 | 1,207 | 2,954 | Upgrade
|
| Total Liabilities & Equity | 1,393 | 1,662 | 1,638 | 2,271 | 3,763 | Upgrade
|
| Total Debt | 355.97 | 363.45 | 286.29 | 174.2 | 83.86 | Upgrade
|
| Net Cash (Debt) | 363.91 | 685.07 | 861.31 | 1,604 | 3,488 | Upgrade
|
| Net Cash Growth | -46.88% | -20.46% | -46.32% | -54.00% | 21.02% | Upgrade
|
| Net Cash Per Share | 0.29 | 0.54 | 0.73 | 1.38 | 3.33 | Upgrade
|
| Filing Date Shares Outstanding | 1,277 | 1,275 | 1,198 | 1,173 | 1,147 | Upgrade
|
| Total Common Shares Outstanding | 1,277 | 1,275 | 1,198 | 1,173 | 1,147 | Upgrade
|
| Working Capital | 407.9 | 479.45 | 300.44 | 1,025 | 2,845 | Upgrade
|
| Book Value Per Share | 0.28 | 0.36 | 0.38 | 1.03 | 2.58 | Upgrade
|
| Tangible Book Value | 202.51 | 283.79 | 289.63 | 1,136 | 2,948 | Upgrade
|
| Tangible Book Value Per Share | 0.16 | 0.22 | 0.24 | 0.97 | 2.57 | Upgrade
|
| Machinery | 13.79 | 14.11 | 19.1 | 18.95 | 16.57 | Upgrade
|
| Construction In Progress | 151.75 | 151.75 | 151.76 | 138.67 | 21.48 | Upgrade
|
| Leasehold Improvements | 21.28 | 21.28 | 21.28 | 20.31 | 19.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.